1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Screening Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Stool-based Tests
1.2.3 Colonoscopy
1.2.4 CT Colonography
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Screening Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Independent Diagnostic Labs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Screening Market Perspective (2017-2028)
2.2 Colorectal Cancer Screening Growth Trends by Region
2.2.1 Colorectal Cancer Screening Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Colorectal Cancer Screening Historic Market Size by Region (2017-2022)
2.2.3 Colorectal Cancer Screening Forecasted Market Size by Region (2023-2028)
2.3 Colorectal Cancer Screening Market Dynamics
2.3.1 Colorectal Cancer Screening Industry Trends
2.3.2 Colorectal Cancer Screening Market Drivers
2.3.3 Colorectal Cancer Screening Market Challenges
2.3.4 Colorectal Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Screening Players by Revenue
3.1.1 Global Top Colorectal Cancer Screening Players by Revenue (2017-2022)
3.1.2 Global Colorectal Cancer Screening Revenue Market Share by Players (2017-2022)
3.2 Global Colorectal Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Screening Revenue
3.4 Global Colorectal Cancer Screening Market Concentration Ratio
3.4.1 Global Colorectal Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Screening Revenue in 2021
3.5 Colorectal Cancer Screening Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Screening Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Screening Breakdown Data by Type
4.1 Global Colorectal Cancer Screening Historic Market Size by Type (2017-2022)
4.2 Global Colorectal Cancer Screening Forecasted Market Size by Type (2023-2028)
5 Colorectal Cancer Screening Breakdown Data by Application
5.1 Global Colorectal Cancer Screening Historic Market Size by Application (2017-2022)
5.2 Global Colorectal Cancer Screening Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Colorectal Cancer Screening Market Size (2017-2028)
6.2 North America Colorectal Cancer Screening Market Size by Country (2017-2022)
6.3 North America Colorectal Cancer Screening Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Colorectal Cancer Screening Market Size (2017-2028)
7.2 Europe Colorectal Cancer Screening Market Size by Country (2017-2022)
7.3 Europe Colorectal Cancer Screening Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Screening Market Size (2017-2028)
8.2 Asia-Pacific Colorectal Cancer Screening Market Size by Country (2017-2022)
8.3 Asia-Pacific Colorectal Cancer Screening Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Screening Market Size (2017-2028)
9.2 Latin America Colorectal Cancer Screening Market Size by Country (2017-2022)
9.3 Latin America Colorectal Cancer Screening Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Screening Market Size (2017-2028)
10.2 Middle East & Africa Colorectal Cancer Screening Market Size by Country (2017-2022)
10.3 Middle East & Africa Colorectal Cancer Screening Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Colorectal Cancer Screening Introduction
11.1.4 Abbott Revenue in Colorectal Cancer Screening Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 Clinical Genomics Technologies
11.2.1 Clinical Genomics Technologies Company Detail
11.2.2 Clinical Genomics Technologies Business Overview
11.2.3 Clinical Genomics Technologies Colorectal Cancer Screening Introduction
11.2.4 Clinical Genomics Technologies Revenue in Colorectal Cancer Screening Business (2017-2022)
11.2.5 Clinical Genomics Technologies Recent Development
11.3 Epigenomics Inc
11.3.1 Epigenomics Inc Company Detail
11.3.2 Epigenomics Inc Business Overview
11.3.3 Epigenomics Inc Colorectal Cancer Screening Introduction
11.3.4 Epigenomics Inc Revenue in Colorectal Cancer Screening Business (2017-2022)
11.3.5 Epigenomics Inc Recent Development
11.4 Exact Sciences
11.4.1 Exact Sciences Company Detail
11.4.2 Exact Sciences Business Overview
11.4.3 Exact Sciences Colorectal Cancer Screening Introduction
11.4.4 Exact Sciences Revenue in Colorectal Cancer Screening Business (2017-2022)
11.4.5 Exact Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Screening Introduction
11.5.4 Roche Revenue in Colorectal Cancer Screening Business (2017-2022)
11.5.5 Roche Recent Development
11.6 Hemosure Inc
11.6.1 Hemosure Inc Company Detail
11.6.2 Hemosure Inc Business Overview
11.6.3 Hemosure Inc Colorectal Cancer Screening Introduction
11.6.4 Hemosure Inc Revenue in Colorectal Cancer Screening Business (2017-2022)
11.6.5 Hemosure Inc Recent Development
11.7 Novigenix SA
11.7.1 Novigenix SA Company Detail
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA Colorectal Cancer Screening Introduction
11.7.4 Novigenix SA Revenue in Colorectal Cancer Screening Business (2017-2022)
11.7.5 Novigenix SA Recent Development
11.8 Quidel
11.8.1 Quidel Company Detail
11.8.2 Quidel Business Overview
11.8.3 Quidel Colorectal Cancer Screening Introduction
11.8.4 Quidel Revenue in Colorectal Cancer Screening Business (2017-2022)
11.8.5 Quidel Recent Development
11.9 Siemens
11.9.1 Siemens Company Detail
11.9.2 Siemens Business Overview
11.9.3 Siemens Colorectal Cancer Screening Introduction
11.9.4 Siemens Revenue in Colorectal Cancer Screening Business (2017-2022)
11.9.5 Siemens Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex Colorectal Cancer Screening Introduction
11.10.4 Sysmex Revenue in Colorectal Cancer Screening Business (2017-2022)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
